Additionally, it suppresses the activation of phosphorylated NF-κB p65 in liver tissues [46], thereby exerting a protective effect against HFD-induced NAFLD by curbing pro-inflammatory LPS release and lipid synthesis [31]. This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.